The burden and management of cytochrome P450 2D6 (CYP2D6)-mediated drug-drug interaction (DDI): co-medication of metoprolol and paroxetine or fluoxetine in the elderly-Reference-Cited by-同舟云学术

The burden and management of cytochrome P450 2D6 (CYP2D6)-mediated drug-drug interaction (DDI): co-medication of metoprolol and paroxetine or fluoxetine in the elderly

Published:2017-03-26 Issue:7 Volume:26 Page:752-765
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Bahar Muh. Akbar¹²^ORCID,Hak Eelko¹,Bos Jens H.J.¹,Borgsteede Sander D.³,Wilffert Bob¹⁴

Affiliation:

1. University of Groningen, Groningen Research Institute of Pharmacy, Department of PharmacoTherapy, -Epidemiology & -Economics; Groningen The Netherlands

2. Hasanuddin University, Faculty of Pharmacy; Makassar Indonesia

3. Health Base Foundation, Department of Clinical Decision Support; Houten The Netherlands

4. University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology; Groningen The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference64 articles.

1. The prevalence of co-prescription of clinically relevant CYP enzyme inhibitor and substrate drugs in community-dwelling elderly Australians;Kerr;J Clin Pharm Ther,2014

2. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy;Doan;Ann Pharmacother,2013

3. Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis;Dechanont;Pharmacoepidemiol Drug Saf,2014

4. Cytochrome P450-mediated cardiovascular drug interactions;Scheen;Expert Opin Drug Metab Toxicol,2011

5. Potential for drug interactions involving cytochromes P450 2D6 and 3A4 on general adult psychiatric and functional elderly psychiatric wards;Davies;Br J Clin Pharmacol,2004

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic and Pharmacodynamic Drug–Drug Interactions: Research Methods and Applications;Metabolites;2023-07-29

2. Efficacy and tolerability of desvenlafaxine in the real-world treatment of patients with major depression: a narrative review and an expert opinion paper;Expert Opinion on Pharmacotherapy;2023-07-23

3. Age-related modifications in CYP-dependent drug metabolism: role of stress;Frontiers in Endocrinology;2023-05-24

4. Interaction alerts: A comparison of classifications and recommendations for clinical management between Janusmed and three other knowledge resources;Basic & Clinical Pharmacology & Toxicology;2023-02-21

5. Determination of CYP450 activities in diabetes mellitus rats by a UHPLC-MS/MS method;Journal of Pharmaceutical and Biomedical Analysis;2023-02